The association between lncRNA H19 expression levels and patients' clinicopathological characteristics, including tumor size, mitotic index, stage at diagnosis, class of risk according to Miettinen's criteria, and c-KIT mutation status are described in Table 2. This evidence concerns the gene H19 and neoplasm.